Neurodegenerative Diseases

At EMD Serono, Inc., we have a strong commitment to neurodegenerative diseases. As part of this commitment, we are dedicated to working to develop new treatment options and devices as well as continuing to enhance patient support services.

Our neurodegenerative disease franchise is our largest, led by our flagship product Rebif® (interferon beta-1a). Rebif® is one of the leading treatments for relapsing forms of multiple sclerosis (MS) in the United States and many other countries worldwide. At EMD Serono, Inc. we are committed to meeting the unmet needs of people living with MS and offer comprehensive education and support services for people living with MS and their care partners. (Click on the Rebif® product name above for additional product and full prescribing information.)

Multiple Sclerosis
Multiple Sclerosis (MS) is a chronic, inflammatory condition of the nervous system, which includes the brain, spinal cord, and optic nerves, and is the most common, non-traumatic, disabling neurological disease in young adults. MS affects approximately two million people worldwide, and more than 400,000 in the United States. While symptoms can vary, the most common symptoms of MS include blurred vision, numbness or tingling in the limbs, and problems with strength and coordination. The relapsing forms of MS are the most common. MS is usually diagnosed between the ages of 20 and 40. It is twice as common in women as in men. Currently, there is no cure for MS.

Important Safety Information
Rebif® should be used with caution in patients with depression, seizure disorders, and liver disease. Common side effects include injection site reactions and flu-like symptoms. For more information on Rebif® visit www.rebif.com or refer to full prescribing information for Rebif®. Patients should be instructed to read the Medication Guide accompanying the product and talk to their doctor.